2012
DOI: 10.1038/nm0712-998b
|View full text |Cite
|
Sign up to set email alerts
|

Execution of sepsis trials needs an overhaul, experts say

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
9
0

Year Published

2012
2012
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 3 publications
0
9
0
Order By: Relevance
“… 14 Our study also goes beyond previous investigations by evaluating a longer term end point (90 days); this endpoint was investigated because patients with sepsis continue to face an increased risk of mortality even after ICU and hospital discharge. 32 …”
Section: Discussionmentioning
confidence: 99%
“… 14 Our study also goes beyond previous investigations by evaluating a longer term end point (90 days); this endpoint was investigated because patients with sepsis continue to face an increased risk of mortality even after ICU and hospital discharge. 32 …”
Section: Discussionmentioning
confidence: 99%
“…A strong research drive and extensive media coverage have served to bring sepsis into public prominence in recent years. A significant factor in the lack of effective treatments for septic shock, in addition to the limitations of related clinical trials ( 28 ), is the problem of research translatability; numerous interventions that have proved beneficial in rodent models have failed to translate into improved outcome in humans ( 38 ). Patient and pathogen heterogeneity, and the confounding effects of clinical intervention, complicate the process of developing a relevant model in which to investigate disease mechanisms.…”
Section: Discussionmentioning
confidence: 99%
“…Human SE transitions from systemic inflammation to a diffuse disturbance in the blood-brain barrier (BBB) associated with a period of neurological dysfunction 4 . Several recent studies have suggested roles for vascular factors in SE-related injury of the brain vascular endothelium, changes in BBB permeability and microcirculatory distress 10 , 11 , 12 , but the contributions of various cell types, cellular receptors and signaling events remain unclear 13 , 14 , 15 . For example, although leukocyte adhesion to activated endothelial cells has been identified as an early event in sepsis-related central nervous system dysfunction 16 , the triggers of this event and the mechanism by which leukocyte adhesion may lead to the development of encephalopathy remain uncertain.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, P2RX 7 activation was shown to amplify lipopolysaccharide (LPS)-induced hyporeactivity in the endothelium-intact mouse aorta 21 . Because brain endothelial activation during sepsis significantly impacts microcirculation and BBB integrity 13 , 14 , 15 , we hypothesized that P2RX 7 plays a critical role in sepsis-induced neurovascular damage. P2RX 7 is an ATP-gated purinoceptor channel that mediates Ca 2+ influx and subsequent downstream intracellular signaling events 22 , 23 .…”
Section: Introductionmentioning
confidence: 99%